PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 Jun 2021 07:00

RNS Number : 5532D
Allied Minds PLC
30 June 2021
 

30 June 2021

 

Allied Minds

 

Transaction in own shares

 

Allied Minds plc (AIM:ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 23 June 2021 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be cancelled.

 

Date of purchase:

 29 June 2021

Aggregate number of Ordinary Shares purchased:

123,563

Lowest price paid per share (GBp):

20.600

Highest price paid per share (GBp):

20.800

Average price paid per share (GBp):

20.6621

 

Following the purchase of these shares, the remaining number of Ordinary Shares in issue will be 241,563,608 (excluding treasury shares), and the Company hold no Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 241,563,608. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

2500

20.72

09:33:08

00052422793TRLO0

LSE

7738

20.80

13:52:10

00052437620TRLO0

LSE

1000

20.80

14:48:53

00052442311TRLO0

LSE

5646

20.60

16:21:05

00052451611TRLO0

LSE

4861

20.60

16:21:05

00052451612TRLO0

LSE

5189

20.60

16:21:05

00052451618TRLO0

LSE

9255

20.60

16:21:06

00052451626TRLO0

LSE

6669

20.60

16:21:06

00052451627TRLO0

LSE

777

20.60

16:21:06

00052451628TRLO0

LSE

954

20.60

16:21:06

00052451629TRLO0

LSE

1774

20.60

16:21:09

00052451638TRLO0

LSE

1869

20.60

16:22:07

00052451763TRLO0

LSE

5567

20.60

16:22:20

00052451782TRLO0

LSE

1953

20.60

16:22:26

00052451790TRLO0

LSE

933

20.60

16:22:26

00052451789TRLO0

LSE

5486

20.60

16:22:26

00052451791TRLO0

LSE

1977

20.60

16:22:26

00052451792TRLO0

LSE

5389

20.60

16:22:26

00052451793TRLO0

LSE

51112

20.71

16:23:53

00052451954TRLO0

LSE

1098

20.60

16:24:52

00052452083TRLO0

LSE

1816

20.60

16:27:51

00052452496TRLO0

LSE

 

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Harry Rein

Instinctif

alliedminds@instinctif.com

Tim Linacre / Rozi Morris / Hannah Campbell

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZVNLFGMZM
Date   Source Headline
13th Nov 20174:42 pmRNSBlocklisting Six Monthly Return
13th Nov 20174:24 pmRNSBlocklisting Six Monthly Return
31st Oct 20174:47 pmRNSTotal Voting Rights
30th Oct 20177:00 amRNSAllied-Bristol Life Sciences forms ABLS IV
25th Oct 20177:00 amRNSAllied Minds Capital Markets Day: 18 January 2018
16th Oct 20177:59 amRNSAllied Minds: STT and TEL to jointly develop MRAM
6th Oct 20174:42 pmRNSTotal Voting Rights
5th Oct 20177:00 amRNSSTT announces $22.8m convertible bridge facility
28th Sep 20177:00 amRNSSciFluor SF0166 study positive top-line results
19th Sep 20177:00 amRNSDirectorate Change
14th Sep 20177:00 amRNSFederated Wireless $42m fundraise & product launch
13th Sep 20174:40 pmRNSSecond Price Monitoring Extn
13th Sep 20174:35 pmRNSPrice Monitoring Extension
1st Sep 201711:43 amRNSTotal Voting Rights
17th Aug 20177:00 amRNSHalf-year Report
8th Aug 20175:36 pmRNSHolding(s) in Company
2nd Aug 20177:00 amRNSNotice of Results
26th Jul 20177:00 amRNSALM subsid Signature Medical $2.5 million Series A
12th Jul 20177:00 amRNSBridgeSat, Inc. appoints Barry Matsumori as CEO
11th Jul 20174:35 pmRNSSpin Transfer Tech's appoints Tom Sparkman CEO
30th Jun 20175:29 pmRNSTotal Voting Rights
29th Jun 20177:00 amRNSAppointment of Head of Technology Investments
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20175:02 pmRNSResult of AGM
30th May 20177:00 amRNSJill Smith Appointed As CEO and President
19th May 20174:58 pmRNSBlock Listing Six Monthly Return
12th May 20172:13 pmRNSBlock Listing of Shares
5th May 20177:00 amRNSBridgeSat raises $6 million in Series A financing
28th Apr 20173:14 pmRNSNotice of AGM; Annual Report
27th Apr 20177:00 amRNSAnnual Financial Report
20th Apr 20174:28 pmRNSHolding(s) in Company
18th Apr 20175:12 pmRNSHolding(s) in Company
7th Apr 20179:41 amRNSHolding(s) in Company
6th Apr 20175:24 pmRNSHolding(s) in Company
5th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20177:00 amRNSReallocation of capital and resources
31st Mar 20173:56 pmRNSTotal Voting Rights
16th Mar 20175:27 pmRNSHolding(s) in Company
13th Mar 20177:00 amRNSJill Smith appointed interim CEO of Allied Minds
1st Mar 20174:45 pmRNSTotal Voting Rights
15th Feb 20172:57 pmRNSHolding(s) in Company
14th Feb 20174:23 pmRNSTotal Voting Rights
7th Feb 20177:00 amRNSHawkEye 360 Completes Second Closing of Series A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.